본문

  1. Home
666 Results:AA:W G IN PP:ELSEVIER INC 0.290 sec.
RSS 
다국어입력
 상세검색
 신착검색
선택출력 선택엑셀내보내기
611
Elevated serum FGF23 concentrations in plasma cell dyscrasias
Elevated serum FGF23 concentrations in plasma cell dyscrasias
Inge Stewart., | Elsevier Inc | 2006 ,
612
The importance of spectrum bias on bone density monitoring in clinical practice
The importance of spectrum bias on bone density monitoring in clinical practice
William D. Leslie., | Elsevier Inc | 2006 ,
613
Tumor necrosis factor-alpha : Alternative role as an inhibitor of osteoclast formation in vitro
Tumor necrosis factor-alpha : Alternative role as an inhibitor of osteoclast formation in vitro
Renate Balga., | Elsevier Inc | 2006 ,
614
Time-lapsed investigation of three-dimensional failure and damage accumulation in trabecular bone using synchrotron light
Time-lapsed investigation of three-dimensional failure and damage accumulation in trabecular bone using synchrotron light
P. J. Thurner., | Elsevier Inc | 2006 ,
615
Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover
Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover
P. D. Delmas., | Elsevier Inc | 2006 ,
616
In vivo skeletal imaging of 18F-fluoride with positron emission tomography reveals damage-and time-dependent responses to fatigue loading in the rat ulna
In vivo skeletal imaging of 18F-fluoride with positron emission tomography reveals damage-and time-dependent responses to fatigue loading in the rat ulna
Matthew J. Silva., | Elsevier Inc | 2006 ,
617
Corrigendum to "Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice" [Bone 36 (2005) 399-407]
Corrigendum to "Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice" [Bone 36 (2005) 399-407]
Yukio Nakamura., | Elsevier Inc | 2006 ,
618
Local bioavailability and distribution of systemically (parenterally) administered ibandronate in the infarcted femoral head
Local bioavailability and distribution of systemically (parenterally) administered ibandronate in the infarcted femoral head
Harry K. W. Kim., | Elsevier Inc | 2006 ,
619
Association of endothelial nitric oxide synthase genotypes with bone mineral density bone loss, hip structure, and risk of fracture in older women : The SOF study
Association of endothelial nitric oxide synthase genotypes with bone mineral density bone loss, hip structure, and risk of fracture in older women : The SOF study
Brent C. Taylor., | Elsevier Inc | 2006 ,
620
Inhibitors of cyclo-oxygenase-2 and secretory phospholipase A2 preserve bone architecture following ovariectomy in adult rats
Inhibitors of cyclo-oxygenase-2 and secretory phospholipase A2 preserve bone architecture following ovariectomy in adult rats
Laura S. Gregory., | Elsevier Inc | 2006 ,
처음이전57585960616263646566이후마지막